Video! Ziosoft has been trying to unlock the U.S. market for advanced visualization for several years. It may have found the key with a technology unveiled this week at RSNA2010.
Ziosoft has been trying to unlock the U.S. market for advanced visualization for several years. It may have found the key with a technology unveiled this week at RSNA2010.
Producing images that border on photorealism, ZioSoft’s new PhyZiodynamic algorithms take postprocessing to a new level, one the Japanese company describes as “functional imaging analytics.” Image data are not only visually striking but measurable and highly reproducible, according to Rob Royea, president and COO for Ziosoft, adding objectivity to what has typically been a subjective medium.
High-resolution 2D data are processed into high-fidelity 3D renderings, which are then animated to demonstrate real-time action. Four-dimensional loops portray dynamic volumetric imaging that allows functional analyses.
The new algorithms are powered by a supercomputing architecture that supports the rendering of 3D and 4D images. The company has harnessed these algorithms to drive functional analysis available on its MR Cardiac Analysis suite on its Ziostation system. Other analyses supported by the algorithms are designed to depict coronary vessels, time intensity, time-delayed signal intensity, and strain analysis of the heart. These are only sold outside the U.S.
PhyZiodynamics is a generational leap ahead in advanced visualization, according to Royea. The underlying basis of the technology is its ability to process images quickly and without data loss, thereby ensuring true fidelity renderings from any DICOM imaging modality.
Because the new PhyZiodynamic offerings are networked, as are all Ziosoft-based technologies, processed images are accessible anywhere throughout the enterprise with multiple concurrent users per off-the-shelf server.
In addition to its new PhyZiodynamic algorithms, the company will feature at its booth a new specialized liver analysis application for surgical and treatment planning. This application allows automatic segmentation of the liver. A guided workflow “wizard" breaks vascular structure, hepatic lobes, and lesions into segments.
AI Facilitates Nearly 83 Percent Improvement in Turnaround Time for Fracture X-Rays
December 19th 2023In addition to offering a 98.5 percent sensitivity rate in diagnosing fractures on X-ray, an emerging artificial intelligence (AI) software reportedly helped reduce mean turnaround time on X-ray fracture diagnosis from 48 hours to 8.3 hours, according to new research presented at the Radiological Society of North America (RSNA) conference.
The Reading Room: Artificial Intelligence: What RSNA 2020 Offered, and What 2021 Could Bring
December 5th 2020Nina Kottler, M.D., chief medical officer of AI at Radiology Partners, discusses, during RSNA 2020, what new developments the annual meeting provided about these technologies, sessions to access, and what to expect in the coming year.
Can an Emerging PET Radiotracer Enhance Detection of Prostate Cancer Recurrence?
December 14th 2023The use of 68Ga-RM2 PET/MRI demonstrated a 35 percent higher sensitivity rate than MRI alone for the diagnosis of biochemical recurrence of prostate cancer, according to research recently presented at the Radiological Society of North America (RSNA) conference.
RSNA 2020: Addressing Healthcare Disparities and Access to Care
December 4th 2020Rich Heller, M.D., with Radiology Partners, and Lucy Spalluto, M.D., with Vanderbilt University School of Medicine, discuss the highlights of their RSNA 2020 session on health disparities, focusing on the underlying factors and challenges radiologists face to providing greater access to care.
Can AI Improve Detection of Extraprostatic Extension on MRI?
December 4th 2023Utilizing a deep learning-based AI algorithm to differentiate between diagnostic and non-diagnostic quality of prostate MRI facilitated a 10 percent higher specificity rate for diagnosing extraprostatic extension on multiparametric MRI, according to research presented at the recent RSNA conference.
Study: Regular Mammography Screening Reduces Breast Cancer Mortality Risk by More than 70 Percent
November 30th 2023Consistent adherence to the five most recent mammography screenings prior to a breast cancer diagnosis reduced breast cancer death risk by 72 percent in comparison to women who did not have the mammography screening, according to new research findings presented at the annual Radiological Society of North America (RSNA) conference.